ப்ரோடீந் இன உறவு பிசின் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ப்ரோடீந் இன உறவு பிசின். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ப்ரோடீந் இன உறவு பிசின் Today - Breaking & Trending Today

Coronavirus Spike Protein Capture Resin Available for Future Deployment

Coronavirus Spike Protein Capture Resin Available for Future Deployment
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

Navigo Proteins , Protein Affinity , Protein Affinity Resin , ப்ரோடீந் இன உறவு , ப்ரோடீந் இன உறவு பிசின் ,

New Affinity Resin for COVID-19 Vaccine Purification

New Affinity Resin for COVID-19 Vaccine Purification
February 12, 2021
Share
Repligen and Navigo Proteins report that they have completed development and started the commercial launch of the NGL COVID-19 Spike Protein Affinity Resin. Working with Navigo Proteins on the ligand development and partnering with Purolite Life Sciences on Praesto
® agarose bead technology, the resulting product meets all the expected requirements of a high-performance resin including very high selectivity, high dynamic binding capacities and caustic stability over multi-cycle use, according to Ralf Kuriyel, senior vice president, R&D, Repligen.
“We are very pleased to launch this resin and are very encouraged by the positive customer feedback on its overall performance in the development and manufacture of spike protein based vaccines,” he said. ....

Henning Afflerbach , Ralf Kuriyel , Purolite Life Sciences On Praesto , Navigo Proteins , Protein Affinity , Purolite Life Sciences , Protein Affinity Resin , ப்ரோடீந் இன உறவு , ப்ரோடீந் இன உறவு பிசின் ,

Repligen Corporation: Repligen and Navigo Proteins Announce the Launch of an Affinity Resin for the Purification of COVID-19 Vaccines

(2)
WALTHAM, Mass. and HALLE (Saale), Germany, Feb. 08, 2021 (GLOBE NEWSWIRE) Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, and Navigo Proteins GmbH ( Navigo ), a premier protein engineering company specializing in novel affinity ligand development, today announced that they have completed the development and initiated the commercial launch of NGL COVID-19 Spike Protein Affinity Resin, a novel affinity resin to be utilized in the purification of COVID-19 vaccines.
The availability of this COVID-19 affinity resin is the result of an accelerated program to provide COVID-19 vaccine manufacturers with a high purity capture step, decreasing processing time and significantly improving overall yield in the production of these critical vaccines. ....

Baden Wuberg , Sondras Newman , Henning Afflerbach , Ralf Kuriyel , Oliver Schub , Exchange Commission , Purolite Life Sciences On Praesto , Exchange Commission Actual , Repligen Corporation , Drug Administration , Business Development , Navigo Proteins Gmbh , Protein Affinity Resin , Navigo Proteins , Purolite Life Sciences , Spike Protein , United States , Rancho Dominguez , Clifton Park , Annual Report , Quarterly Report , Co Vid , பரிமாற்றம் தரகு , பரிமாற்றம் தரகு உண்மையானது , வணிக வளர்ச்சி , ப்ரோடீந் இன உறவு பிசின் ,

Repligen and Navigo Proteins Announce the Launch of an Affinity Resin for the Purification of ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ....

Baden Wuberg , Sondras Newman , Henning Afflerbach , Ralf Kuriyel , Oliver Schub , Exchange Commission , Purolite Life Sciences On Praesto , Exchange Commission Actual , Repligen Corporation , Drug Administration , Business Development , Navigo Proteins Gmbh , Protein Affinity Resin , Navigo Proteins , Purolite Life Sciences , Spike Protein , Precision Capturing , United States , Rancho Dominguez , Clifton Park , Annual Report , Quarterly Report , Investor Relations , Public Health , Products And Services , Coronavirus Pandemic ,